Bevacizumab Combined With Chemotherapy in the Second-Line Treatment of Metastatic Colorectal Cancer: Results from the Phase II BEVACOLOR Study
Authors:
- Christophe BorgCBChristophe Borg
- Jean-Pierre DelordJDJean-Pierre Delord
- Faress HusseiniFHFaress Husseini
- Véronique Trillet-LenoirVTVéronique Trillet-Lenoir
- Roger FarouxRFRoger Faroux
- Eric FrançoisEFEric François
- Marc YchouMYMarc Ychou
- François GoldwasserFGFrançois Goldwasser
- Olivier BouchéOBOlivier Bouché
- Helene SenellartHSHelene Senellart
- Sandrine KraemerSKSandrine Kraemer
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 11 (1) , 38-44
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatmentAnnals of Oncology, 2010
- Oxaliplatin Plus Irinotecan Compared With Irinotecan Alone as Second-Line Treatment After Single-Agent Fluoropyrimidine Therapy for Metastatic Colorectal CarcinomaJournal of Clinical Oncology, 2008
- Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority studyAnnals of Oncology, 2008
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyJournal of Clinical Oncology, 2008
- Phase II Trial Alternating FOLFOX-6 and FOLFIRI Regimens in Second-Line Therapy of Patients with Metastatic Colorectal Cancer (FIREFOX Study)Cancer Investigation, 2006
- Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2005
- Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal CancerJournal of Clinical Oncology, 2005
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyJournal of Clinical Oncology, 2004
- Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2003